SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech Valuation -- Ignore unavailable to you. Want to Upgrade?

To: bio_kruncher who wrote (13250)9/30/2004 4:13:47 PM
From: Biomaven  Read Replies (2) | Respond to of 52153
 
Risk was doubled at 3 year point.
15/1000 for Vioxx 7.5/1000 for Placebo

Ouch. But where's Miljenko when we need him to point out that it's less than a 1% absolute risk increase? <g>

Peter



To: bio_kruncher who wrote (13250)9/30/2004 4:50:25 PM
From: Biotech Jim  Read Replies (1) | Respond to of 52153
 
What is your source for the risk differential? It was not mentioned in either the PR or the conference call.

TIA.

Bj


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News